realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

October 31, 2025

Study Completion Date

August 31, 2026

Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG

Tafasitamab

Observational Study on safety and effectiveness of tafasitamab in combination with lenalidomide inPatients With Relapsed or Refractory DLBCL.

Trial Locations (25)

10532

RECRUITING

Westchester Medical Center, Hawthorne

19096

COMPLETED

Lankenau Medical Center, Wynnewood

19107

RECRUITING

Thomas Jefferson University, Philadelphia

20817

RECRUITING

American Oncology Partners of Maryland PA, Bethesda

27705

RECRUITING

VA Medical Center - Durham, Durham

27858

RECRUITING

Leo Jenkins Cancer Center/ECU School of Medicine, Greenville

28204

RECRUITING

Levine Cancer Institute, Charlotte

35211

RECRUITING

Alabama Oncology, Birmingham

35805

RECRUITING

Clearview Cancer Institute, Huntsville

43302

RECRUITING

Ohio Health Marion Area Physicians, Marion

44646

RECRUITING

Tri County Hematology & Oncology Associates, Inc, Massillon

44708

RECRUITING

Mercy Medical Center, Canton

48109

RECRUITING

University of Michigan Comprehensive Cancer Center Michigan Medicine, Ann Arbor

48202

RECRUITING

Henry Ford Health System, Detroit

50010

RECRUITING

McFarland Clinic P.C., Ames

50309

RECRUITING

Mission Cancer and Blood, Des Moines

53226

RECRUITING

Froedtert & Medical College Clinics, Milwaukee

70112

COMPLETED

Tulane Cancer Center, New Orleans

73142

RECRUITING

Integris Cancer Institute of Oklahoma, Oklahoma City

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

92868

RECRUITING

University of California, Irvine Medical Center, Orange

98109

RECRUITING

UW Medicine, Seattle

98902

RECRUITING

Yakima Valley Memorial Hospital/North Star Lodge, Yakima

07960-6136

RECRUITING

Morristown Medical Center, Morristown

08903-2681

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY